Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer - Business Wire
HealthcareOther
Gilead→Arcellx
Apr 17, 2026
Gilead — Acquisitions & M&A Deals
3 dealsTracking 3 M&A deals by Gilead.
Gilead to Acquire Tubulis, Strengthing Oncology Pipeline - CHEManager.
HealthcarePlatform
Gilead→Tubulis
Apr 16, 2026
Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
HealthcarePlatform
Gilead→Tubulis
Apr 7, 2026